​The National COVID-19 vaccination programme (NVP) aims to protect Singaporeans against severe disease, minimising the risk of transmission, and protects our healthcare system from being overwhelmed. Public Health Preparedness Clinics (PHPCs) are encouraged to participate in the NVP to support our national efforts in providing COVID-19 vaccination to our residents.


​Pfizer-BioNTech/Comirnaty and Moderna/Spikevax have been authorised by the Health Sciences Authority (HSA) for use in Singapore and are currently offered under the NVP.

Under the NVP, vaccinations are free for all Singaporean Citizens, Permanent Residents, long-term visit pass holders and certain short-term visit pass holders.​

Please refer to the following Operations Instructions for information about the administration of the vaccinations under the NVP for the different patient age groups:


​Pfizer-BioNTech/Comirnaty XBB 1.5 Monovalent Vaccine


Moderna/Spikevax XBB 1.5 Vaccine

  • For Infants (6 months to 5 years of age)

  • For Paediatrics (6 to 11 years of age)

  • For Adults (12 years and above)​


​Novavax/Nuvaxovid and Sinovac/CoronaVac have been authorised by the Health Sciences Authority (HSA) for use in Singapore and are currently offered under the private vaccination programme.

Please refer to the following Operations Instructions for information about the administration of the vaccinations under the private vaccination programme:

​Novavax/Nuvaxovid XBB 1.5 Monovalent Vaccine

  • For Adults (12 years and above)

Sinovac/CoronaVac Vaccine

  • For Adults (18 years and above)​